Crossmark

Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study

Crossref DOI link: https://doi.org/10.1007/s10147-024-02563-7

Published Online: 2024-06-04

Published Print: 2024-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanabe, Kenji

Kobayashi, Shuichiro https://orcid.org/0009-0000-7290-1826
Maezawa, Yuya

Ishihara, Kensaku

Inoue, Naoki

Izumi, Keita

Fujiwara, Motohiro

Toide, Masahiro

Yamamoto, Takanobu

Uehara, Sho

Araki, Saori

Inoue, Masaharu

Takazawa, Ryoji

Numao, Noboru

Ohtsuka, Yukihiro

Tanaka, Hajime

Yoshida, Soichiro

Fujii, Yasuhisa
License Information

Text and Data Mining valid from 2024-06-04

Version of Record valid from 2024-06-04
More Information

Article History

Received: 26 March 2024

Accepted: 28 May 2024

First Online: 4 June 2024

Declarations

:

: None.

Document is current

Any future updates will be listed below